Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Retained Earnings (2010 - 2026)

Exelixis (EXEL) posted quarterly Retained Earnings of -$215.8 million for Q2 2026, down 10836.02% year-over-year from N/an in Q2 2025, and down 180.87% quarter-over-quarter from -$76.8 million in Q1 2026.

Analysis

Exelixis (EXEL) Retained Earnings (2010 - 2026) Analysis & Trends

Exelixis' Retained Earnings history runs 17 years deep, the most recent figure standing at -$215.8 million for Q2 2026.

  • In Q2 2026, Retained Earnings fell 10836.02% year-over-year to -$215.8 million; the TTM figure through Apr 2026 stood at -$215.8 million (down 10836.02% YoY), while the FY2026 annual figure was -$76.8 million, up 22.12% from the prior year.
  • Retained Earnings for Q2 2026 stood at -$215.8 million, down from -$76.8 million in the prior quarter.
  • The five-year high for Retained Earnings was $2.6 billion in Q1 2023, with the low at -$258.9 million in Q1 2024.
  • The 5-year median for Retained Earnings is $1.3 million (2025), against an average of $815.7 million.
  • The sharpest annual moves came in 2023 and 2026: Retained Earnings surged 61486.23% in 2023, then slumped 10836.02% in 2026.
  • Exelixis' Retained Earnings stood at -$14.5 million in 2022, then slumped by 1093.8% to -$173.4 million in 2023, then surged by 1462.25% to $2.4 billion in 2024, then sank by 99.85% to $3.6 million in 2025, then sank by 6153.13% to -$215.8 million in 2026.
  • Business Quant data shows EXEL's Retained Earnings at -$215.8 million in Q2 2026, -$76.8 million in Q1 2026, and $3.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 2.11 Bn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 2.11 Bn
Apr 3, 2026 2.15 Bn
Jan 2, 2026 2.23 Bn
Oct 3, 2025 2.26 Bn
Jul 4, 2025 2.25 Bn
Apr 4, 2025 2.29 Bn
Jan 3, 2025 2.34 Bn
Sep 27, 2024 2.36 Bn
Jun 28, 2024 2.32 Bn
Mar 29, 2024 2.39 Bn
Dec 29, 2023 2.44 Bn
Sep 29, 2023 2.49 Bn
Jun 30, 2023 2.53 Bn
Mar 31, 2023 2.56 Bn
Dec 30, 2022 2.54 Bn
Sep 30, 2022 2.51 Bn
Jul 1, 2022 2.48 Bn
Apr 1, 2022 2.45 Bn
Dec 31, 2021 2.43 Bn
Oct 1, 2021 2.42 Bn